Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod.
Tasquinimod is an orally active anticancer drug in late clinical development. Here we describe the development and validation of a bioanalytical method based upon dried blood spot analysis in combination with LCMS/MS and stable isotope dilution.